- Home
- TEVA vs FISV Comparison
TEVA vs FISV Comparison
Compare TEVA & FISV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TEVA | FISV |
|---|---|---|
| Founded | 1901 | 1984 |
| Country | Israel | United States |
| Employees | N/A | 38000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2B | 34.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TEVA | FISV |
|---|---|---|
| Price | $33.65 | $61.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 28 |
| Target Price | $37.25 | ★ $146.17 |
| AVG Volume (30 Days) | 7.8M | ★ 8.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.97 | $4.31 |
| P/E Ratio | $28.19 | ★ $9.94 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.47 | $57.79 |
| 52 Week High | $37.35 | $70.41 |
Technical Indicators
Market Signals| Indicator | TEVA | FISV |
|---|---|---|
| Relative Strength Index (RSI) | 51.67 | 49.42 |
| Support Level | $30.70 | $57.79 |
| Resistance Level | $35.32 | $68.87 |
| Average True Range (ATR) | 0.80 | 2.48 |
| MACD | -0.23 | 0.23 |
| Stochastic Oscillator | 18.07 | 63.62 |
Price Performance
Historical ComparisonAbout TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About FISV Fiserv Inc.
Fiserv is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing, for US banks and credit unions, with a focus on small and midsize banks. Following its 2019 merger with First Data, Fiserv also provides payment processing services to merchants. About 10% of the company's revenue is generated internationally.